Oncoinvent ASA (ONCIN) — Strategic Asset Allocation Index
Oncoinvent ASA (ONCIN) has a Strategic Asset Allocation Index of 0.1% as of June 2025. Strategic assets (PP&E of Nkr75.00K plus long-term investments of Nkr-) total Nkr75.00K, measured against net assets of Nkr67.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Oncoinvent ASA (ONCIN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Oncoinvent ASA Strategic Asset Allocation Index (2022–2025)
This chart shows how Oncoinvent ASA's Strategic Asset Allocation Index has evolved across 4 annual periods from 2022 to 2025. As of June 2025, the index stands at 0.1%, representing strategic assets of Nkr75.00K against net assets of Nkr67.00 Million NOK. See ONCIN financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Oncoinvent ASA (2022–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Oncoinvent ASA from 2022 to 2025, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Oncoinvent ASA market cap and net worth.
| Year | SAAI | Strategic Assets (NOK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 10.6% | Nkr15.58 Million | Nkr15.58 Million | Nkr- | Nkr146.32 Million | ▲ +9.5 pp |
| 2024 | 1.2% | Nkr1.25 Million | Nkr1.25 Million | Nkr- | Nkr108.33 Million | ▲ +0.8 pp |
| 2023 | 0.3% | Nkr431.00K | Nkr431.00K | Nkr- | Nkr127.48 Million | ▲ +0.3 pp |
| 2022 | 0.0% | Nkr43.00K | Nkr43.00K | Nkr- | Nkr88.50 Million | — |